Ardelyx, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (30)

Latest Posts

About This Stock More About This Stock
Week In Review: Fosun Signs $125 Million Deal For Ardelyx IBS Treatment
Article By: ChinaBio® Today
Saturday, December 16, 2017 5:21 PM EDT
Fosun Pharma obtained China rights to tenapanor, an Ardelyx treatment for irritable bowel syndrome with constipation (IBS-C), in a $125 million agreement. Tenapanor is also expected to treat hyperphosphatemia related to chronic kidney disease.
In this article: HCM, ARDX, LLY
Read
5 Breakout Stocks Offering Phenomenal Returns
Article By: Swarup Gupta
Friday, July 7, 2017 9:55 AM EDT
Stocks which have breached their resistance level should ideally be in high demand among traders. But the test of whether this is a genuine breakout is whether they go on to attain higher prices and the old barrier becomes a new support.
In this article: ARDX, NVAX, BIOS, LAYN, RESN
Read
Ardelyx Shares Plummet 37% Despite Passing Primary Endpoint Of Phase 3
Article By: Terry Chrisomalis
Friday, May 12, 2017 10:58 AM EDT
Ardelyx shares plummeted 37% despite passing the primary endpoint of a phase 3 study. The company tested its drug Tenapanor in phase 3, clinical trial known as T3MPO-1.
In this article: ARDX Also: SGYP
Read
Is Ardelyx Inc A Good Stock To Buy Right Now?
Article By: Insider Monkey
Saturday, December 10, 2016 5:20 PM EDT
ARDX was in 13 hedge funds' portfolios at the end of September up from nine the previous quarter. The level and the change in hedge fund popularity aren't the only variables you need to analyze to decipher hedge funds' perspectives.
In this article: NPK, TCBK, ARDX, NTLA
Read
4 Likely Biotech Takeover Targets To Buy
Article By: Bret Jensen
Saturday, July 23, 2016 4:53 PM EDT
After biotech stock Relypsa was bought out last week for a 60% premium, the odds of M&A heating up in this sector increased dramatically. Bret Jensen shares four more likely takeover targets that should be on your watchlist.
In this article: ACAD, ARDX, SGYP Also: SNY, MDVN, PGNX, RLYP, AZN, BIIB, ZSPH, AGN, VRX
Read

PARTNER HEADLINES

Latest Tweets for $ARDX

No tweets yet!